Clotilde Bravetti
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 10
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 9
- Co-authors
- Marine Armand (5 shared papers)Frédéric Davi (7 shared papers)Damien Roos‐Weil (7 shared papers)Denis Monneret (1 shared paper)Cécile Emeraud (1 shared paper)Marine Baron (4 shared papers)Dominique Bonnefont‐Rousselot (1 shared paper)Françoise Imbert‐Bismut (1 shared paper)
- Journals
- British Journal of Haematology (2 papers)Blood Advances (1 paper)BMC Biology (1 paper)Haematologica (1 paper)HemaSphere (1 paper)
- Partner nations
- FranceNetherlandsGermany
In The Last Decade
Clotilde Bravetti
13 papers receiving 114 citations
Peers
Comparison fields: 5 of 31
- Genetics 50
- Pathology and Forensic Medicine 35
- Hematology 15
- Immunology 24
- Physiology 23
Countries citing papers authored by Clotilde Bravetti
This map shows the geographic impact of Clotilde Bravetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clotilde Bravetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clotilde Bravetti more than expected).
Fields of papers citing papers by Clotilde Bravetti
This network shows the impact of papers produced by Clotilde Bravetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clotilde Bravetti. The network helps show where Clotilde Bravetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Clotilde Bravetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 28 | |
| 2 | 2021 | 27 | |
| 3 | 2022 | 17 | |
| 4 | 2023 | 14 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2025 | 0 |
About Clotilde Bravetti
Clotilde Bravetti is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Neurology, having authored 15 papers that have together received 117 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Viral-associated cancers and disorders (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Genetics (50 citations), Pathology and Forensic Medicine (35 citations), Hematology (15 citations), Immunology (24 citations) and Physiology (23 citations). Clotilde Bravetti has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Marine Armand, Frédéric Davi, Damien Roos‐Weil, Denis Monneret, Cécile Emeraud, Marine Baron, Dominique Bonnefont‐Rousselot, Françoise Imbert‐Bismut, Élise Chapiro and Florence Nguyen‐Khac. Their work appears in journals such as British Journal of Haematology, Blood Advances, BMC Biology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.